XML 37 R22.htm IDEA: XBRL DOCUMENT v3.25.1
SHAREHOLDERS' EQUITY AND SHARE-BASED COMPENSATION
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
SHAREHOLDERS' EQUITY AND SHARE-BASED COMPENSATION SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION
Common Stock
As of December 31, 2024, we had 100.0 million shares authorized, 30.0 million issued and 27.2 million shares of common stock outstanding. As of December 31, 2023, we had 100.0 million shares authorized, 30.0 million shares issued and 26.5 million shares of common stock outstanding. The holders of shares of Altisource common stock generally are entitled to one vote for each share on all matters voted on by shareholders, and the holders of such shares generally will possess all voting power.
On February 18, 2025, the Company’s shareholders approved an increase in the number of authorized shares from 100.0 million to 250.0 million and a decrease in the par value of the Company’s common stock from $1.00 to $0.01. See Note 24, Subsequent Events.
On February 19, 2025, the Company issued 58.2 million shares of common stock to lenders under the SSTL. See Note 24, Subsequent Events.
Equity Incentive Plan
Our 2009 Equity Incentive Plan (the “Plan”) provides for various types of equity awards, including stock options, stock appreciation rights, stock purchase rights, restricted shares, RSUs and other awards, or a combination of any of the above. Under the Plan, we may grant up to 11.7 million Altisource share-based awards to officers, directors, employees and to employees of our affiliates. As of December 31, 2024, 4.0 million share-based awards were available for future grant under the Plan. Expired and forfeited awards are available for reissuance.
On February 18, 2025, the Company’s shareholders approved an increase in the number of Altisource share-based awards that may be granted from 11.7 million to 16.3 million. See Note 24, Subsequent Events.
Share Repurchase Program
On May 16, 2023, our shareholders approved the renewal and amendment of the share repurchase program previously approved by the shareholders on May 15, 2018. Under the program, we are authorized to purchase up to 3.1 million shares of our common stock, based on a limit of 15% of the outstanding shares of common stock on the date of approval, at a minimum price of $1.00 per share and a maximum price of $25.00 per share, for a period of five years from the date of approval. As of December 31, 2024, approximately 3.1 million shares of common stock remain available for repurchase under the program. There were no purchases of shares of common stock during the years ended December 31, 2024 and 2023. Under the Amended Credit Agreement, we are not permitted to repurchase shares except for limited circumstances.
Public offerings of Common Stock
On February 14, 2023, Altisource closed on an underwritten public offering to sell 4,550,000 shares of its common stock, at a price of $5.00 per share, generating net proceeds of $20.5 million, after deducting the underwriting discounts and commissions and other offering expenses.
On September 7, 2023, Altisource closed on an underwritten public offering to sell 5,590,277 shares of its common stock, at a price of $3.60 per share, generating net proceeds of $18.4 million, after deducting the underwriting discounts and commissions and other offering expenses.
Share-Based Compensation
We issue share-based awards in the form of stock options, restricted shares and RSUs for certain employees, officers and directors. We recognized share-based compensation expense of $4.7 million and $5.1 million for the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024, estimated unrecognized compensation costs related to share-based awards amounted to $1.2 million, which we expect to recognize over a weighted average remaining requisite service period of approximately 0.98 years.
Stock Options
Stock option grants are composed of a combination of service-based, market-based and performance-based options.
Service-Based Options. These options generally vest over three or four years with equal annual vesting and generally expire on the earlier of ten years after the date of grant or following termination of service. A total of 165 thousand service-based options were outstanding as of December 31, 2024.
Market-Based Options. These option grants generally have two components, each of which vests only upon the achievement of certain criteria. The first component, which we refer to as “ordinary performance” grants, generally consists of two-thirds of the market-based grant and begins to vest if the stock price is at least double the exercise price, as long as the stock price realizes a compounded annual gain of at least 20% over the exercise price. The remaining third of the market-based options, which we refer to as “extraordinary performance” grants, generally begins to vest if the stock price is at least triple the exercise price, as long as the stock price realizes a compounded annual gain of at least 25% over the exercise price. Market-based options generally vest in three or four year installments with the first installment vesting upon the achievement of the criteria and the remaining installments vesting thereafter in equal annual installments. Market-based options generally expire on the earlier of ten years after the date of grant or following termination of service, unless the performance criteria is met prior to termination of service or in the final three years of the option term, in which case vesting will generally continue in accordance with the provisions of the award agreement. A total of 54 thousand market-based options were outstanding as of December 31, 2024.
Performance-Based Options. These option grants generally will vest if certain specific financial measures are achieved; typically with one-fourth vesting on each anniversary of the grant date. The award of performance-based options is adjusted based on the level of achievement specified in the award agreements. If the performance criteria achieved is above threshold performance levels, participants generally have the opportunity to vest in 50% to 200% of the option grants, depending upon performance achieved. If the performance criteria achieved is below a certain threshold, the options are canceled. The options generally expire on the earlier of ten years after the date of grant or following termination of service, unless the performance criteria is met prior to termination of service in which case vesting will generally continue in accordance with the provisions of the award agreement. There were 461 thousand performance-based options outstanding as of December 31, 2024.
There were no stock option grants during the years ended December 31, 2024 and 2023.
We determined the expected option life of all service-based stock option grants using the simplified method, determined based on the graded vesting term plus the contractual term of the options, divided by two. We use the simplified method because we believe that our historical data does not provide a reasonable basis upon which to estimate expected option life.
The following table summarizes the grant date fair value of stock options that vested during the years ended December 31:
(in thousands, except per share data)20242023
Weighted average grant date fair value of stock options granted per share$— $— 
Intrinsic value of options exercised— — 
Grant date fair value of stock options that vested$98 $98 
The following table summarizes the activity related to our stock options:
 Number of optionsWeighted average exercise price
Weighted average contractual term (in years)
Aggregate intrinsic value (in thousands)
Outstanding as of December 31, 2023739,189 $27.04 4.83$— 
Granted— — 
Forfeited(58,947)88.10 
Outstanding as of December 31, 2024680,242 21.75 3.11— 
Exercisable as of December 31, 2024536,226 23.29 2.41— 
The following table summarizes information about stock options outstanding and exercisable as of December 31, 2024:
Options outstandingOptions exercisable
Exercise price range (1)
Number
Weighted average remaining contractual life (in years)
Weighted average exercise priceNumber
Weighted average remaining contractual life (in years)
Weighted average exercise price
$10.01 — $20.00
245,100 3.69$15.40 137,436 1.12$17.96 
$20.01 — $30.00
408,110 2.1624.81 382,758 2.1724.77 
$30.01 — $40.00
27,032 1.6533.24 16,032 1.6433.66 
680,242 536,226 
______________________________________
(1) These options contain market-based and performance-based components as described above.
The following table summarizes the market prices necessary in order for the market-based options to begin to vest:
Market-based options
Vesting priceOrdinary performanceExtraordinary performance
$50.01 — $60.00
7,581 4,162 
$60.01 — $70.00
7,333 6,250 
$80.01 — $90.00
— 3,791 
$90.01 — $100.00
— 3,667 
Total14,914 17,870 
Weighted average share price$30.12 $24.60 
Other Share-Based Awards
The Company’s other share-based and similar types of awards are comprised of restricted shares and RSUs. The restricted shares and RSUs are comprised of a combination of service-based awards, performance-based awards, market-based awards and performance and market-based awards.
Service-Based Awards. These awards generally vest over one-to-four year periods. A total of 1,507 thousand service-based awards were outstanding as of December 31, 2024.
Performance-Based Awards. These awards generally vest if certain specific financial measures are achieved; generally one-third vests on each anniversary of the grant date or cliff-vest on the third anniversary of the grant date. The number of performance-based restricted shares and RSUs that may vest is based on the level of achievement as specified in the award agreements. If the performance criteria achieved is above certain financial performance levels and Altisource’s share performance is above certain established criteria, participants have the opportunity to vest in up to 150% of the RSU award for certain awards. If the performance criteria achieved is below certain thresholds, the award is canceled. A total of 190 thousand performance-based awards were outstanding as of December 31, 2024.
Market-Based Awards. 50% of these awards generally vest if certain specific market conditions are achieved over a 30-day period and the remaining 50% of these awards generally vest on the one year anniversary of the initial vesting. The Company estimates the grant date fair value of these awards using a lattice (binomial) model. A total of 112 thousand market-based awards were outstanding as of December 31, 2024.
Performance-Based and Market-Based Awards. These awards generally vest if certain specific financial measures are achieved and if certain specific market conditions are achieved. If the performance criteria achieved is above certain financial performance levels and Altisource’s share performance is above certain established criteria, participants have the opportunity to vest in up to 300% of the RSU award for certain awards. If the performance criteria or the market criteria is below certain thresholds, the award is canceled. The Company estimates the grant date fair value of these awards using a
Monte Carlo simulation model. A total of 189 thousand performance-based and market-based awards were outstanding as of December 31, 2024.
The Company granted 1,725 thousand RSUs (at a weighted average grant date fair value of $2.39 per share) during the year ended December 31, 2024. These grants included 88 thousand performance-based awards and 88 thousand awards that include both a performance condition and a market condition. The Company granted 891 thousand RSUs (at a weighted average grant date fair value of $4.82 per share) during the year ended December 31, 2023. These grants included 57 thousand performance-based awards and 57 thousand awards that include both a performance condition and a market condition.
The following table summarizes the activity related to our restricted shares and RSUs:
 Number of restricted shares and restricted
share units
Outstanding as of December 31, 20231,262,742 
Granted1,724,910 
Issued(633,597)
Forfeited / canceled
(356,168)
Outstanding as of December 31, 20241,997,887 
The following assumptions were used to determine the fair values for the awards that include both a performance condition and a market condition for the years ended December 31:
 20242023
Risk-free interest rate (%)4.09 4.18 
Expected stock price volatility (%)66.24 62.13 
Expected dividend yield— — 
Expected life (in years)33
Fair value$— $9.63 
On February 13, 2025, the Company granted 4.6 million RSUs (at a weighted average grant date fair value of $1.06 per share) to senior management in connection with the Transactions (defined in Note 24) under the Plan. See Note 24, Subsequent Events.